Adrenomedullin and truncated peptide adrenomedullin(22-52) affect chondrocyte response to apoptotis in vitro: downregulation of FAS protects chondrocyte from cell death
Related Experiment Video
Updated: Dec 6, 2025

Author Spotlight: Exploring the Role of FAM83A in Cervical Cancer
Published on: February 9, 2024
Frédéric Velard1, Aurore Chatron-Colliet1, Dominique Côme1
1INSERM, UMR-S 1132 Bioscar, Centre Viggo Petersen, Hôpital Lariboisière, 2, Rue Ambroise Paré, 75010, Paris, France.
Abstract:
Chondrocyte apoptosis may have a pivotal role in the development of osteoarthritis. Interest has increased in the use of anti-apoptotic compounds to protect against osteoarthritis development. In this work, we investigated the effect of adrenomedullin (AM), a 52 amino-acid hormone peptide, and a 31 amino-acid truncated form, AM(22-52), on chondrocyte apoptosis. Bovine articular chondrocytes (BACs) were cultured under hypoxic conditions to mimic cartilage environment and then treated with Fas ligand (Fas-L) to induce apoptosis. The expression of AM and its calcitonin receptor-like receptor (CLR)/receptor activity-modifying protein (RAMP) (receptor/co-receptor) was assessed by immunostaining. We evaluated the effect of AM and AM(22-52) on Fas-L-induced chondrocyte apoptosis. FAS expression was appreciated by RT-qPCR and immunostainings. The expression of hypoxia-inducible factor 1α (HIF-1α), CLR and one co-receptor (RAMP2) was evidenced. With BACs under hypoxia, cyclic adenosine monophosphate production increased dose-dependently with AM stimulation. AM significantly decreased caspase-3 activity (mean 35% decrease; p = 0.03) as a marker of Fas-L-induced apoptosis. Articular chondrocytes treated with AM showed significantly reduced cell death, along with downregulated Fas expression and production, as compared with AM(22-52). AM decreased articular chondrocyte apoptosis by downregulating a Fas receptor. These findings may pave the way for novel therapeutic approaches in osteoarthritis.
Insights
Adrenomedullin (AM) protects against osteoarthritis by reducing chondrocyte apoptosis. AM significantly decreased cell death and Fas receptor expression in bovine articular chondrocytes, suggesting potential therapeutic applications.
Area of Science:
- Biochemistry
- Cell Biology
- Osteoarthritis Research
Background:
- Chondrocyte apoptosis plays a key role in osteoarthritis (OA) development.
- Anti-apoptotic compounds are being explored for OA prevention and treatment.
Purpose of the Study:
- To investigate the effects of adrenomedullin (AM) and its truncated form AM(22-52) on chondrocyte apoptosis.
- To assess the potential of AM as a therapeutic agent for OA.
Main Methods:
- Bovine articular chondrocytes (BACs) were cultured under hypoxia and treated with Fas ligand (Fas-L) to induce apoptosis.
- AM and AM(22-52) treatments were applied, and apoptosis markers (caspase-3 activity, cell death, Fas expression) were measured.
- Expression of AM, CLR, RAMP, and HIF-1α was assessed using immunostaining and RT-qPCR.
Main Results:
- AM significantly reduced Fas-L-induced chondrocyte apoptosis, decreasing caspase-3 activity by 35% (p=0.03).
- AM treatment led to significantly reduced cell death and downregulated Fas expression compared to AM(22-52).
- Hypoxia-inducible factor 1α (HIF-1α), calcitonin receptor-like receptor (CLR), and receptor activity-modifying protein 2 (RAMP2) were expressed in BACs.
Conclusions:
- Adrenomedullin (AM) effectively decreases chondrocyte apoptosis by downregulating the Fas receptor.
- AM demonstrates potential as a novel therapeutic strategy for osteoarthritis.
- Further research into AM-based therapies for OA is warranted.
More Related Videos
08:30Chondrogenic Differentiation Induction of Adipose-derived Stem Cells by Centrifugal Gravity
Published on: February 24, 2017
09:18Identification of Intracellular Signaling Events Induced in Viable Cells by Interaction with Neighboring Cells Undergoing Apoptotic Cell Death
Published on: December 27, 2016
Related Concept Videos
The Extrinsic Apoptotic Pathway
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The Intrinsic Apoptotic Pathway